| NCT Number | NCT06763666 |
| Lead Sponsor | Nanfang Hospital, Southern Medical University
Collaborators: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou No.12 People's Hospital, Guangzhou Panyu Central Hospital, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou First People's Hospital, Foresea Life Insurance Guangzhou General Hospital, Guangdong Second Provincial General Hospital, Jiangmen Central Hospital, Shantou Central Hospital, Maoming People's Hospital, First Affiliated Hospital of Guangxi Medical University, Hainan General Hospital, Dongguan People's Hospital, Tungwah Hospital of Sun Yat-Sen University, Shenzhen Hospital of Southern Medical University, Central People's Hospital of Zhanjiang, ZhuHai Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, LiuZhou People's Hospital, First People's Hospital of Foshan, Southern Medical University, China, Affiliated Hospital of Guangdong Medical University, Guilin Medical University, China, Yuebei People's Hospital, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Guangzhou Medical University, Peking University Shenzhen Hospital |
| Conditions | Relapsed/Refractory AML |
| Enrollment | 172 participants |
| Start Date | 2025-02 |
| Primary Completion | 2025-06 (estimated) |
| Study Completion | 2025-12 (estimated) |
| Updated on ClinicalTrials.gov | 2025-01-08 |